Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kempf

Showing results (351-360 of 415) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strainsChen Zhao, Hing L Sham, Minghua Sun, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ringTodd W Rockway, Rong Zhang, Dachun Liu, et al.
Frontiers in Medicine|November 5, 2025
<i>Enterococcus faecium</i> DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunctionOlaf Tyc, Nico Kraus, Toska Wiedemann, et al.
Annals of Hematology|September 25, 2020
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapyOlivier Ballo, Eva-Maria Kreisel, Fagr Eladly, et al.
Bioorganic & Medicinal Chemistry|March 1, 2006
Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitorsJohn T Randolph, Peggy P Huang, William J Flosi, et al.
Journal of Clinical Microbiology|September 17, 2020
Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessusNils Wetzstein, Thomas A Kohl, Tilman G Schultze, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Quantitative Phosphoproteomics of the Angiotensin AT<sub>2</sub>-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and ApoptosisA Augusto Peluso, Stefan J Kempf, Thiago Verano-Braga, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavirD J Kempf, K C Marsh, G Kumar, et al.
Nature Communications|September 11, 2024
The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumanniiChun Kew, Cristian Prieto-Garcia, Anshu Bhattacharya, et al.
Journal of Medicinal Chemistry|December 4, 2009
Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocketKoushi Hidaka, Tooru Kimura, Hamdy M Abdel-Rahman, et al.
Pageof 42

Showing results (351-360 of 415) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strainsChen Zhao, Hing L Sham, Minghua Sun, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2006
Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ringTodd W Rockway, Rong Zhang, Dachun Liu, et al.
Frontiers in Medicine|November 5, 2025
<i>Enterococcus faecium</i> DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunctionOlaf Tyc, Nico Kraus, Toska Wiedemann, et al.
Annals of Hematology|September 25, 2020
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapyOlivier Ballo, Eva-Maria Kreisel, Fagr Eladly, et al.
Bioorganic & Medicinal Chemistry|March 1, 2006
Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitorsJohn T Randolph, Peggy P Huang, William J Flosi, et al.
Journal of Clinical Microbiology|September 17, 2020
Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessusNils Wetzstein, Thomas A Kohl, Tilman G Schultze, et al.
Hypertension (Dallas, Tex. : 1979)|September 9, 2022
Quantitative Phosphoproteomics of the Angiotensin AT<sub>2</sub>-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and ApoptosisA Augusto Peluso, Stefan J Kempf, Thiago Verano-Braga, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavirD J Kempf, K C Marsh, G Kumar, et al.
Nature Communications|September 11, 2024
The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumanniiChun Kew, Cristian Prieto-Garcia, Anshu Bhattacharya, et al.
Journal of Medicinal Chemistry|December 4, 2009
Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocketKoushi Hidaka, Tooru Kimura, Hamdy M Abdel-Rahman, et al.
Pageof 42